SCHEMBL8317551

SCHEMBL8317551

CS(=O)(=O)N(c1[c]cccc1)S(C)(=O)=O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1043536 0.82 KMT2A (0.38)
SCHEMBL11345030 0.76 APOBEC3G (0.45)
SCHEMBL10661809 0.76 KDM4E (0.30)
SCHEMBL16295402 0.76 NNMT (0.33)
SCHEMBL11342191 0.73 TDP1 (0.36)
SCHEMBL7849449 0.72 SMN1; SMN2 (0.51) KEAP1
SCHEMBL5387281 0.72 KIF11 (0.34)
SCHEMBL6599939 0.72 TSHR (0.36)
SCHEMBL7839475 0.71 KEAP1 (0.39) KEAP1
SCHEMBL2536094 0.71 KCNE1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934940-A1 CYTOKINE PRODUCTION INHIBITORS, TRIAZEPINE COMPOUNDS, AND INTERMEDIATES THEREOF Japan Tobacco Inc. (JP) 1999-08-11 EP disclosed
US-5807850-A Therapeutic agent for osteoporosis and triazepine compound JAPAN TOBACCO, INC. (JP) 1998-09-15 US disclosed
EP-0792880-A1 OSTEOPOROSIS REMEDY AND TRIAZEPINE COMPOUND Japan Tobacco Inc. (JP) 1997-09-03 EP disclosed